Medigen Biotechnology Corp (基亞生技) shares continued to lose value, recording a 19th day of falling to the maximum daily limit of 7 percent yesterday, after investor sentiment weakened over the failure of its new drug for liver cancer to pass clinical trials, dealers said.
The Medigen share sell-off also spread to other biotech stocks and even to small and medium-sized non-biotech stocks in the over-the-counter (OTC) market, the dealers said.
Shares of Medigen fell to NT$113 at the close with 143,000 shares changing hands. The index on the OTC market, where the stock is traded, ended down 0.41 percent at 134.53 points.
The stock opened down 7 percent and selling continued without any sign of fading, keeping the share price weak throughout the session, dealers said.
Even after the market closed, investors placed orders to sell 7.8 million more Medigen shares, indicating that the stock could trend even lower, perhaps even dropping as low as NT$100 over the next few sessions.
On July 27, Medigen’s new liver cancer drug — PI-88 — failed to pass interim analysis in clinical trials. Starting from the July 28 trading session, Medigen shares started to decline steeply, registering a loss of about 74 percent.
After the plunge in share prices, the market capitalization of the company fell by NT$45 billion.
Due to the price volatility, Medigen shares have been downgraded to a “full-delivery stock” that cannot be traded on the margins by investors, further reducing investor interest, traders said.
Medigen said the clinical trials are continuing and still require final analysis, and it is therefore too early to say that the development of the new drug has failed.
The sell-off in Medigen shares led many investors to sell other stocks in both the biotech and non-biotech sectors throughout the session, the dealers said.
Among the affected stocks were LED product supplier Yang Hwa Technology Corp and electronics component maker Podak Co.
Both fell by the maximum 7 percent to close at NT$62.50 and NT$36.45, respectively.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the